---
title: "Recor Medical gains first US FDA renal denervation approval"
date: "2023-11-08T10:01:38.000Z"
publishedDate: "8 novembre 2023"
summary: "Recor Medical has become the first company in the USA to have a device-based therapy approved for the treatment of hypertension, after it was announced that the US Food and Drug Administration (FDA) has approved the company’s Paradise ultrasound renal denervation (RDN) system this week. The Paradise system is intended as an adjunctive treatment option [&#8230;] The post Recor Medical gains first US FDA renal denervation approval appeared first on Interventional News ."
importance: ""
sourceUrl: "https://interventionalnews.com/paradise-renal-denervation-fda-approval/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2023-11-08-recor-medical-gains-first-us-fda-renal-denervation-approval"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2023/11/Paradise_3D_Cath-Sonication_10-2022.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/paradise-renal-denervation-fda-approval/"
---

![Recor Medical gains first US FDA renal denervation approval](https://interventionalnews.com/wp-content/uploads/sites/13/2023/11/Paradise_3D_Cath-Sonication_10-2022.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/paradise-renal-denervation-fda-approval/*

## L’essentiel

Recor Medical has become the first company in the USA to have a device-based therapy approved for the treatment of hypertension, after it was announced that the US Food and Drug Administration (FDA) has approved the company’s Paradise ultrasound renal denervation (RDN) system this week. The Paradise system is intended as an adjunctive treatment option [&#8230;] The post Recor Medical gains first US FDA renal denervation approval appeared first on Interventional News .

## Lien source

https://interventionalnews.com/paradise-renal-denervation-fda-approval/
